Showing results (161-170 of 6,853) with videos related to
Sort By:
Pageof 686
The Journal of Infectious Diseases|June 14, 2011
Global eradication of measles: an epidemiologic and economic evaluationAnn Levin, Colleen Burgess, Louis P Garrison, et al.Contemporary Clinical Trials|September 18, 2012
The value of comparative effectiveness research: projected return on investment of the RxPONDER trial (SWOG S1007)William B Wong, Scott D Ramsey, William E Barlow, et al.Journal of Medical Economics|October 13, 2012
Ipilimumab in 2nd line treatment of patients with advanced melanoma: a cost-effectiveness analysisVictor Barzey, Michael B Atkins, Louis P Garrison, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 25, 2024
Estimating the Allocation of the Economic Value Generated by Utilization of All-Oral Direct-Acting Antivirals for Hepatitis C in the United States, 2015 to 2019Louis P Garrison, Boshen Jiao, Zizi Elsisi, et al.Cancer|June 19, 2013
Assessing the potential cost-effectiveness of retesting IHC0, IHC1+, or FISH-negative early stage breast cancer patients for HER2 statusLouis P Garrison, Deepa Lalla, Melissa Brammer, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 12, 2019
Projected Cost-Effectiveness for 2 Gene-Drug Pairs Using a Multigene Panel for Patients Undergoing Percutaneous Coronary InterventionM Ragan Hart, Louis P Garrison, Debra L Doyle, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 13, 2019
Cost-Effectiveness Analysis of Pertuzumab With Trastuzumab and Chemotherapy Compared to Trastuzumab and Chemotherapy in the Adjuvant Treatment of HER2-Positive Breast Cancer in the United StatesLouis P Garrison, Joseph Babigumira, Clément Tournier, et al.BMC Health Services Research|October 23, 2009
Potential impact of task-shifting on costs of antiretroviral therapy and physician supply in UgandaJoseph B Babigumira, Barbara Castelnuovo, Mohammed Lamorde, et al.Pharmacoeconomics|September 24, 2021
Principles of Economic Evaluation in a Pandemic Setting: An Expert Panel Discussion on Value Assessment During the Coronavirus Disease 2019 PandemicYumi Asukai, Andrew Briggs, Louis P Garrison, et al.Public Health Genomics|April 22, 2010
Stakeholder perspectives on a risk-benefit framework for genetic testingJoshua A Roth, Louis P Garrison, Wylie Burke, et al.Pageof 686